SAN.PA
Sanofi SA
Price:  
78.90 
EUR
Volume:  
1,897,662.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAN.PA EV/EBITDA

41.2%
Upside

As of 2026-04-29, the EV/EBITDA ratio of Sanofi SA (SAN.PA) is 4.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SAN.PA's latest enterprise value is 110,118.00 mil EUR. SAN.PA's TTM EBITDA according to its financial statements is 23,715.00 mil EUR. Dividing these 2 quantities gives us the above SAN.PA EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.6x - 8.9x 8.1x
Forward P/E multiples 11.0x - 12.3x 11.5x
Fair Price 72.08 - 161.78 111.37
Upside -8.6% - 105.1% 41.2%
78.90 EUR
Stock Price
111.37 EUR
Fair Price

SAN.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-28 4.65
2026-04-27 4.64
2026-04-24 4.70
2026-04-23 4.79
2026-04-22 4.74
2026-04-21 4.75
2026-04-20 4.80
2026-04-17 4.80
2026-04-16 4.74
2026-04-15 4.76
2026-04-14 4.75
2026-04-13 4.67
2026-04-10 4.71
2026-04-09 4.75
2026-04-08 4.74
2026-04-07 4.73
2026-04-02 4.83
2026-04-01 4.85
2026-03-31 4.84
2026-03-30 4.80
2026-03-27 4.80
2026-03-26 4.76
2026-03-25 4.70
2026-03-24 4.59
2026-03-23 4.54
2026-03-20 4.59
2026-03-19 4.61
2026-03-18 4.50
2026-03-17 4.54
2026-03-16 4.52
2026-03-13 4.52
2026-03-12 4.52
2026-03-11 4.51
2026-03-10 4.51
2026-03-09 4.49
2026-03-06 4.52
2026-03-05 4.58
2026-03-04 4.66
2026-03-03 4.69
2026-03-02 4.77
2026-02-27 4.81
2026-02-26 4.74
2026-02-25 4.74
2026-02-24 4.73
2026-02-23 4.74
2026-02-20 4.68
2026-02-19 4.65
2026-02-18 4.58
2026-02-17 4.60
2026-02-16 4.57